Bookbuilding IPO | ₹2,144 Cr | Listed at BSE, NSE | Wed, Jun 16, 2021 - Fri, Jun 18, 2021
KIMS IPO is a book build issue of ₹2,143.92 crores. The issue is a combination of fresh issue of 0.24 crore shares aggregating to ₹200.94 crores and offer for sale of 2.36 crore shares aggregating to ₹1,942.98 crores.
KIMS IPO bidding started from Jun 16, 2021 and ended on Jun 18, 2021. The allotment for KIMS IPO was finalized on Jun 23, 2021. The shares got listed on NSE and BSE on Jun 28, 2021.
KIMS IPO is set final issue price at ₹825 per share. The lot size for an application is 18 shares. The minimum amount of investment required by an individual investor (retail) is ₹14,850 (18 shares) (based on upper price). The lot size investment for sNII is 14 lots (252 shares), amounting to ₹2,07,900, and for bNII, it is 68 lots (1,224 shares), amounting to ₹10,09,800.
The issue includes a reservation of up to 2,54,777 shares for employees offered at a discount of ₹40.00 to the issue price.
Axis Capital Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to KIMS IPO RHP for detailed Information.
IPO Open
Wed, Jun 16, 2021
IPO Close
Fri, Jun 18, 2021
Issue Price
₹825 per share
Market Cap (Pre-IPO)
₹6,602.46 Cr
| IPO Date | 16 to 18 Jun, 2021 |
| Listed on | Mon, Jun 28, 2021 |
| Face Value | ₹10 per share |
| Price Band | ₹815 to ₹825 |
| Issue Price | ₹825 per share |
| Lot Size | 18 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Employee Discount | ₹40.00 |
| Total Issue Size | 2,59,97,133 shares (agg. up to ₹2,144 Cr) |
| Fresh Issue | 24,36,595 shares (agg. up to ₹201 Cr) |
| Offer for Sale | 2,35,60,538 shares of ₹10 (agg. up to ₹1,943 Cr) |
| Share Holding Pre Issue | 7,75,93,283 shares |
| Share Holding Post Issue | 8,00,29,878 shares |
| BSE Script Code / NSE Symbol | 543308 / KIMS |
| ISIN | INE967H01025 |
KIMS IPO comprises a total issue size of 2,59,97,133 shares. The net offer to the public is 2,57,42,356 shares, after excluding 2,54,777 shares under a preferential allotment. Of the Net offer 1,93,06,768 (75.00%) are allocated to QIB, 38,61,353 (15.00%) allocated to NII 25,74,235 (10.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue | Max Allottees |
|---|---|---|---|---|
| QIB Shares Offered | 1,93,06,768 | 75.00% | 74.26% | NA |
| − Anchor Investor Shares Offered | 1,15,84,060 | 44.56% | NA | |
| − QIB (Ex. Anchor) Shares Offered | 77,22,708 | 29.71% | NA | |
| NII (HNI) Shares Offered | 38,61,353 | 15.00% | 14.85% | NA |
| Retail Shares Offered | 25,74,235 | 10.00% | 9.90% | 1,43,013 |
| Preferential Reservations | ||||
| Employee Shares Offered | 2,54,777 | 0.98% | NA | |
| Total Shares Offered | 2,59,97,133 | 100.00% | 100.00% | |
Investors can bid for a minimum of 18 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 18 | ₹14,850 |
| Retail (Max) | 13 | 234 | ₹1,93,050 |
| S-HNI (Min) | 14 | 252 | ₹2,07,900 |
| S-HNI (Max) | 67 | 1,206 | ₹9,94,950 |
| B-HNI (Min) | 68 | 1,224 | ₹10,09,800 |
KIMS IPO raises ₹955.68 crore from anchor investors. KIMS IPO Anchor bid date is June 15, 2021.
| Bid Date | Tue, Jun 15, 2021 |
| Shares Offered | 1,15,84,060 |
| Anchor Portion (₹ Cr.) | 955.68 |
| Anchor lock-in period end date for 50% shares (30 Days) | Fri, Jul 23, 2021 |
| Anchor lock-in period end date for remaining shares (90 Days) | Tue, Sep 21, 2021 |
| Category | Limit | Cut-off |
|---|---|---|
| RII | Up to ₹2 Lakhs | Yes |
| sNII | ₹2 Lakhs – ₹10 Lakhs | No |
| bNII | Above ₹10 Lakhs | No |
| Employee (EMP) | Up to ₹2 Lakhs | Yes |
| Employee + RII/NII | Up to ₹2Lakhs (EMP) + RII/NII limits | Yes (EMP/RII) |
Incorporated in 1973, Krishna Institute of Medical Sciences Limited (KIMS) is one of the largest healthcare groups in AP and Telangana. KIMS provides multi-disciplinary healthcare services with a key focus on primary, secondary, & tertiary care in tier 2-3 cities. The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.
As of March 31, 2021, it operates through 9 multi-speciality hospitals under the brand name of "KIMS Hospitals" with an aggregate bed capacity of 3,064 under the "KIMS Hospitals" brand, with an aggregate bed capacity of 3,064 including over 2,500 operational beds.
Competitive strengths
| Period Ended | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|
| Assets | 1,436.15 | 1,195.89 | 1,119.71 |
| Total Income | 1,340.10 | 1,128.73 | 923.87 |
| Profit After Tax | 205.48 | 115.07 | -48.81 |
| EBITDA | 381.05 | 251.08 | 86.82 |
| NET Worth | 863.73 | 598.13 | 540.66 |
| Reserves and Surplus | 786.14 | 523.64 | 466.17 |
| Total Borrowing | 270.47 | 320.78 | 288.10 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment/pre-payment, in full or part, of certain borrowings availedby our Companyand by ourSubsidiaries vizKHKPL, SIMSPL and KHEPL | 150.00 |
| 2 | General corporate purposes | 41.66 |
The KIMS IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | Subscription (times) | Shares Offered | Shares bid for | |
|---|---|---|---|---|
| Total | 2.52 | 2,59,97,133 | 6,55,02,702 | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to the BRLMs (including underwriting commission, brokerage and selling commission payable to members of the syndicate) | 59.70 |
| 2 | Selling commission and processing fees for SCSBs (1)(2) and Bidding Charges(3)(4)for Members of the Syndicate, Registered Brokers(5), RTAs and CDPs | 2.84 |
| 3 | Fees payable to the Registrar to the Offer | 1.03 |
| 4 | Listing fees, SEBI filing fees, book building software fees and other regulatory expenses | 6.85 |
| 5 | Printing and stationery expenses, advertising and marketing expenses for the Offer and fees payable to the legal counsels | 6.50 |
| 6 | Other Advisors to the Offer | 10.94 |
| 7 | Miscellaneous | 1.50 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹825.00 | ₹825.00 |
| Open | ₹1,008.90 | ₹1,009.00 |
| Low | ₹950.00 | ₹950.00 |
| High | ₹1,057.95 | ₹1,059.00 |
| Last Trade | ₹995.90 | ₹996.95 |
Lead Manager Reports
KIMS IPO is a main-board IPO of 2,59,97,133 equity shares of the face value of ₹10 aggregating up to ₹2,144 Crores. The issue is priced at ₹825 per share. The minimum order quantity is 18.
The IPO opens on Wed, Jun 16, 2021, and closes on Fri, Jun 18, 2021.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in KIMS IPO using UPI as a payment gateway. Zerodha customers can apply in KIMS IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in KIMS IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The KIMS IPO opens on Wed, Jun 16, 2021 and closes on Fri, Jun 18, 2021.
KIMS IPO lot size is 18, and the minimum amount required for application is ₹14,850.
You can apply in KIMS IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for KIMS IPO will be done on Wednesday, June 23, 2021, and the allotted shares will be credited to your demat account by Fri, Jun 25, 2021. Check the KIMS IPO allotment status.
The KIMS IPO listing date is on Mon, Jun 28, 2021.
